Shoppers Drug Mart may have yet to receive its medical cannabis license from Health Canada, but it is moving full steam ahead to make sure it has secured multiple Canadian cannabis suppliers to provide its customers with products.
Tag Archives: Health Canada
OTTAWA, Ontario, Jan. 29, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce the approval by Health Canada of a Phase 2 clinical trial designed to evaluate the safety and efficacy of different doses and ratios of medical cannabis oil (THC & CBD) to improve uncontrolled chronic pain in cancer and non-cancer patients.
OTTAWA, Ontario, Jan. 25, 2018 /Weed Wire/ – Health Canada is introducing two targeted changes to the physical security requirements under the Access to Cannabis for Medical Purposes Regulations (ACMPR) that must be respected by licensed producers (LP) of cannabis for medical purposes.
OTTAWA, Ontario, Jan. 16, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD), Health Canada to evaluate the safety, pharmacokinetics and pharmacodynamics of its cannabis oil PPP005.
Shoppers Drug Mart marijuana is one step closer to reality after a public Canadian marijuana company announced that it has signed on to be the Canadian pharmacy chain’s second medical marijuana supplier.
A new Health Canada survey shows that Canadian cannabis users are hazy on the risks of driving while under the influence of the drug.
OTTAWA, Ontario, Dec. 19, 2017 /Weed Wire/ — Between March and May 2017, Health Canada asked 9,215 Canadians about their knowledge, behaviours and attitudes towards cannabis use, including driving behaviours after consuming cannabis.
VICTORIA, British Columbia, Dec. 15, 2017 /Weed Wire/ — Northern Vine Labs (“Company”), a subsidiary of Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) and Abattis Bioceuticals Corp. (“Abattis”) (CSE: ATT; OTC: ATTBF), today announced that Health Canada has approved an amendment to the Company’s dealer’s license.
OTTAWA, Ontario, Dec. 06, 2017 /Weed Wire/ — Cannabis Canada Association is pleased to announce Sundial Growers Inc. (“Sundial”) as the association’s newest member.
VICTORIA, British Columbia, Nov. 28, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) announced today that its licensed producer application (submitted through its subsidiary, Emerald Health Botanicals) for its new Richmond, BC greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (“OMC”).
A Vancouver cannabis company is scrambling to keep up with a flood of orders for marijuana-filled advent calendars, but the novel take on a popular Christmas tradition has some health experts ringing alarms.
OTTAWA, Ontario, Nov. 22, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that the Canadian Government’s Proposed Approach to the Regulation of Cannabis further confirms the strategic direction of its business model, and that the company is in an excellent position to commercialize natural health products and drugs post-legalization for both the pet and human markets.
OTTAWA, Ont., Nov. 21, 2017 /Weed Wire/ — The current approach to cannabis does not work. Earlier this year, the Government of Canada introduced Bill C-45, the proposed Cannabis Act, to legalize, strictly regulate and restrict access to cannabis. Bill C-45 aims to keep cannabis out of the hands of Canadian youth and the profits away from criminals and organized crime.
RICHMOND, British Columbia, Nov. 15, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) announced today that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (”OMC”).
OTTAWA, Ontario, Nov. 10, 2017 /Weed Wire/ — Today, Health Canada hosted a one-day public education symposium with approximately 90 representatives from federal, provincial and territorial governments, Indigenous groups, and health and other partner organizations that play a role in raising awareness and educating Canadians about the health and safety risks of cannabis use.
TORONTO, Ontario, Nov. 7, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce 7ACRES has commenced production in the newly constructed flowering rooms recently approved by Health Canada.
Shares of Canopy Growth Corp. (TSX:WEED) have climbed a stunning 53.8% month over month as of close on November 1. With all of this in mind, has Canopy established itself as the premier cannabis stock for Canadians?
Enforcing Canada’s new legal weed comes with a high price tag. The federal government will spend C$546 million ($426 million) over the next five years to implement its new cannabis laws, according to the latest budget forecast.
TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) announced today that 7ACRES has obtained the Health Canada approvals necessary to commence cultivation at the recently completed 30,000 sq. ft. flowering rooms at the Company’s Hybrid facility.
VICTORIA, British Columbia, Oct. 19, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH; OTCQX: EMHTF), through Emerald Health Botanicals Inc. (“Emerald”), its wholly owned subsidiary and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), has submitted license applications to Health Canada for approval of two new growing sites.
TORONTO, Ontario, Oct. 4, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that 7ACRES has completed construction of three additional 10,000 sq. ft. flowering rooms at its Hybrid Facility, and applied to Health Canada for licensing.
While Canada is planning to delay the roll out of recreational cannabis edibles for regulatory reasons, it may give stakeholders the added benefit of having extra time to master their formulations for what may become a booming market segment.
Canadian teens curious about cannabis will be the target of a new awareness campaign being launched by Health Canada.
A Quebec company has received the first kosher certification granted to medical marijuana products in Canada.
Landmark legislation has led to the first serious deal in terms of shipping cannabis globally, with an initial consignment of dried medical cannabis already on its way to Germany for distribution. Now that Aurora are the proud recipients of a Health Canada issued Export Permit, they can legally send medical cannabis to Germany.
It seems as though news of recalls related to specific batches of bad marijuana from licensed Canadian producers has been coming in more frequently than marijuana investors and consumers would like to see.
The Canadian government is moving quickly to legalize marijuana and, unlike the patchwork state-by-state approach unfolding in the U.S., Canada is set to make it legal nationwide by this time next year.
In total, four marijuana stocks jumped higher by at least 10% last week. Let’s take a brief look at some of these moves.
Well, we have news for Canadian marijuana stock investors: There’s a new threat on the horizon, at least for our neighbors to the north.
The chief executive of licensed marijuana producer Aphria Inc. is calling on his competitors to disclose and reduce their production costs well in advance of the coming legal recreational market.
MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.
OTTAWA, Ont., June 23, 2017 /Weed Wire/ — I welcome the publication of the “Lower-Risk Cannabis Use Guidelines” today in the American Journal of Public Health. The Canadian Institutes of Health Research supported the development of these Guidelines through funding provided to the Canadian Research Initiative in Substance Misuse.
According to a press release from Health Canada in late May, big changes are coming to the country’s medical cannabis program.
The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.
In late May, MedReleaf priced its public offering at just over $7 per share. The marijuana stock IPO raised a whopping $75 million. Unfortunately, things didn’t work out as planned for pot investors or MedReleaf.
It is apparent that Aphria Inc. will be one of the major winners among marijuana companies. The timing of when to buy shares might be a bit tougher, though.
Canadian band, the Tragically Hip are hoping to get ahead by a few days, partnering with a Canadian medical marijuana company just before it’s set to go public.
OTTAWA, Ontario, May 26, 2017 /Weed Wire/ — Health Canada is introducing several improvements to its medical cannabis program that aim to streamline the application process for issuing production licenses and enable increased production under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
On May 19, 2017, Beleave Inc. (CNX:BE) announced that its subsidiary, First Access Medical Inc., had been awarded a cultivation license from Health Canada, prompting the Canadian cannabis stock to rise 7.62% on Friday.
Canada’s licensed producers will have to expand their testing checklists. On May 5, 2017, Health Canada announced that mandatory cannabis testing now includes testing for unauthorized pesticides.
TORONTO, Ontario, May 5, 2017 /Weed Wire/ – Cronos Group Inc.’s (TSXV:MJN) wholly owned licensed producer, the Peace Naturals Project Inc. (“Peace”), was notified on May 4, 2017 by Health Canada that upon testing a random cannabis leaf sample, trace levels of Piperonyl Butoxide (PBO) were discovered at 0.78 parts per million (ppm). PBO is an organic compound known as a synergist.
OTTAWA, Ontario, May 5, 2017 /Weed Wire/ – Today, Health Canada is announcing that it will require all licensed producers to conduct mandatory testing of all cannabis products destined for sale for the presence of unauthorized pesticides.
Canada’s biggest licensed marijuana producer, Canopy Growth, plans to subject its products to enhanced testing for pesticides and other contaminants, as the industry seeks to restore consumer confidence amid a tainted cannabis scare.
OTTAWA, Ontario, April 13, 2017 /Weed Wire/ — Cannabis Canada, the leading organization of companies that hold Health Canada licenses to cultivate and sell medical cannabis, welcomes the legislation tabled today by the Government of Canada to legalize, regulate, and restrict access to cannabis.
OTTAWA, Canada, April 13, 2017 /Weed Wire/ — The current approach to cannabis does not work. It has allowed criminals and organized crime to profit, while failing to keep cannabis out of the hands of Canadian youth. In many cases, it is easier for our kids to buy cannabis than cigarettes.
While shares have backed off the 52 week highs, Aurora Cannabis is making another run towards the highs as investor enthusiasm increases over recreational marijuana legalization in Canada. Here’s the insider scoop and why we like Aurora Cannabis Inc.
Shoppers Drug Mart spokesperson Tammy Smitham told CityNews that “effective immediately prescriptions for medical marijuana will be covered up to an annual maximum of $1,500.” Loblaw employees would also be covered. Loblaw owns Shoppers.
Marijuana stocks may have leapt higher on the news of Ottawa’s plans to legalize the drug by next year, but the industry is facing an uphill battle in building trust with Canadian consumers, according to a new survey.
Investors are becoming more and more impressed with the job CEO Terry Booth and his team are doing at Aurora Cannabis Inc. After posting strong Q2 results and closing a C$75 million financing, there’s a lot to like with company.
Canopy Growth’s recently acquired Mettrum Ltd. stated that it wrote off $800,000 of costs owing to a series of recalls over the use of a banned pesticides. The staff at Mettrum feared detection from authorities, so they hid the pesticides in the office’s ceiling tiles.